Key result
Elevated systemic inflammatory biomarkers link to higher PAD risk, led most strongly by SIRI.
Why the study?
Are immune-inflammatory biomarkers (NLR, MLR, SII, SIRI, and AISI) associated with lower extremity peripheral arterial disease risk?
Are immune-inflammatory biomarkers (NLR, MLR, SII, SIRI, and AISI) associated with lower extremity peripheral arterial disease risk?
Answers are grounded in this paper and cite their sources.
Immune-inflammatory biomarkers, particularly SIRI, are independently associated with the risk of lower extremity peripheral arterial disease.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question. Immune-inflammatory biomarkers NLR, MLR, SII, SIRI, and AISI were independently associated with peripheral arterial disease risk, with SIRI demonstrating a stronger association.
Synapse has enriched 10 related papers. Consider them for comparative context: